Gad Soffer, EVP & Chief Strategy Officer at Atara Biotherapeutics, Inc. (ATRA), sold 21,546 shares at $15.62 ($334K) on 2017-02-16, disclosed to the SEC on 2017-02-16.
Open-market sale of $334k ATRA by EVP & Chief Strategy Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.22 | 7,000 | $107K | 31.9% |
| 2 | $15.62 | 7,273 | $114K | 34.0% |
| 3 | $15.62 | 7,273 | $114K | 34.0% |
| Total | $15.49 avg | 21,546 | $334K | 100% |
| Filing → |
| ATRA | SELL | 2017-08-17 | $141K | — | Filing → |
| ATRA | SELL | 2017-05-17 | $192K | — | Filing → |
| ATRA | SELL | 2017-03-13 | $50K | — | Filing → |